Obelis GROUP

Obelis GROUP Since 1988 Obelis is assisting non-EU manufacturers’ successful endeavour into Europe. www.obelis.net.

Obelis European Authorized Representatives Center (O.E.A.R.C.) & European Responsible Person Center (O.E.R.P.C.) is a quality driven, service oriented company with over 20 years of experience with European Regulation. Obelis operates as one of the largest regulatory centers in Europe today, providing CE marking & Authorized Representative services for Medical Devices, In-Vitro Diagnostics as well

as “EU Responsible Person” and Cosmetic Notification services in Europe. While still retaining a special expertise in Medical Devices & Cosmetics, Obelis services cover most of the NEW Approach European Directives (Directives requiring either a CE marking or authorized representative – such as medical devices, in-vitro diagnostics, machinery, personal protective equipment, pressure equipment, radio and telecommunication equipment, electrical equipment, low voltage equipments, cosmetics, toys and many more). Obelis is a veteran member of the E.A.A.R ( the European Association of Authorized Representatives).Obelis is active within the EU commission major committees (Medical Device Vigilance committee and IVD Technical committee, Cosmetic Annex I Committee and more) - providing its clients and collaborators with the directions of the Commission before hand. Specialties
Medical Devices, In-Vitro Diagnostics, Cosmetics, Authorized Representative / Responsible Person

🔎Industry Insights for EU Medical Devices The European Parliament voted to urgently update the MDR & IVDR, aiming to tac...
07/01/2025

🔎Industry Insights for EU Medical Devices

The European Parliament voted to urgently update the MDR & IVDR, aiming to tackle key issues like device shortage, SME-friendly measures, and innovative tech fast-tracking by Q1 2025.

Key Resolutions:
🔹Streamlined Regulations: Simplify processes, reduce administrative burdens, and improve transparency, especially for SMEs.
🔹Device Availability: Tackle shortages and ensure equitable access to devices across the EU.
🔹Support for Innovation: Fast-track pathways for groundbreaking technologies and tailored rules for orphan and paediatric devices.
🔹EUDAMED Rollout: Prioritize full implementation for better coordination and information sharing.

How will these reforms impact you? Need help navigating these changes? Reach out to us for expert guidance! 😁

🚀Join Us at Arab Health 2025!We’re excited to announce our participation at Arab Health 2025 in Dubai, from 27-30 Januar...
06/01/2025

🚀Join Us at Arab Health 2025!

We’re excited to announce our participation at Arab Health 2025 in Dubai, from 27-30 January. Join our regulatory expert’s team at Booth Z1/H57A to explore how we can streamline your compliance and accelerate your market entry!

Ready to connect? Book a meeting with us now, and let’s shape the future of healthcare together.

👉 Book a meeting here: https://zurl.co/bookameeting

Happy New Year! 🎉As we welcome 2025, we’re grateful for the incredible support we received in 2024 and look forward to n...
02/01/2025

Happy New Year! 🎉

As we welcome 2025, we’re grateful for the incredible support we received in 2024 and look forward to new goals, fresh ideas, and bigger achievements in the year ahead. Wishing you a joyful, prosperous, and innovative New Year!

Let’s make 2025 our best year yet!

🚨 New IVDR Legacy Period Extension 🚨The new Regulation (EU) 2024/1860, published on 9 July 2024, extends the legacy peri...
30/07/2024

🚨 New IVDR Legacy Period Extension 🚨

The new Regulation (EU) 2024/1860, published on 9 July 2024, extends the legacy period for IVDs. Key dates:

🔹Class D: Until 31 Dec 2027

🔹Class C: Until 31 Dec 2028

🔹Class B & A Sterile: Until 31 Dec 2029

Requirements include applying to a notified body and having a compliant QMS by set deadlines. Obelis is here to assist with compliance and QMS implementation.

Read the full article -> https://www.obelis.net/news/extended-ivdr-legacy-period-officially-published/

Obelis Group at Cosmoprof Las Vegas! 🎉📅 July 23 - 25, 2024 📍 Mandalay Bay Convention Center, Las VegasYesterday was our ...
24/07/2024

Obelis Group at Cosmoprof Las Vegas! 🎉

📅 July 23 - 25, 2024

📍 Mandalay Bay Convention Center, Las Vegas

Yesterday was our first day at Cosmoprof Las Vegas, and it was fantastic!

We connected with many cosmetic professionals and shared insights about our regulatory compliance and market entry services. The energy and innovation in the beauty industry are truly inspiring.

If you're attending, don't miss the chance to meet with us and discover how we can help your business thrive. Schedule a meeting today!

🔗 Schedule a meeting -> https://lnkd.in/eaY57FXz

🚨 Live Webinar: General Product Safety - Get Ready for December 2024 Deadline! 📅 Date: Thursday, July 18, 2024🕓 Time: 4:...
17/07/2024

🚨 Live Webinar: General Product Safety - Get Ready for December 2024 Deadline!

📅 Date: Thursday, July 18, 2024

🕓 Time: 4:00 PM - 5:00 PM (UTC+02:00) Brussels, Copenhagen, Madrid, Paris

🎙️ Speaker: Katerina Svambergova, Regulatory Expert

Agenda:

🔹 Transition from Directive (GPSD) to Regulation (GPSR): Key requirements to be compliant with GPSR.

🔹 EU Responsible Person vs. European Authorised Representative: Differences and obligations.

🔹 Online Sales: New requirements for distance selling and who needs to comply.

⏳ Join our upcoming webinar to gain a comprehensive understanding of these crucial topics!

🔗 Register now to secure your spot ->https://lnkd.in/eGKhBmKS

📢 IVDR Legacy RoadmapCheck out our comprehensive roadmap for navigating the IVDR legacy transition! 🛤️Also, don't miss t...
10/07/2024

📢 IVDR Legacy Roadmap

Check out our comprehensive roadmap for navigating the IVDR legacy transition! 🛤️

Also, don't miss these crucial updates:

🔸IVD Legacy Manufacturers: Important Deadlines & Steps - Ensure you're up to date with key deadlines and necessary actions. https://lnkd.in/ewPt5kSM

🔸Newly Published Q&A from the European Commission - Get the latest insights on the new Regulation amending EU MDR & IVDR. https://lnkd.in/deyX6U76

Stay informed and compliant!

💡

🚀 MHRA's AI Regulatory Strategy for Medical Devices This Spring, the MHRA unveiled its approach to AI in medical product...
04/07/2024

🚀 MHRA's AI Regulatory Strategy for Medical Devices

This Spring, the MHRA unveiled its approach to AI in medical products, building on the Government’s 2023 White Paper, ‘A pro-innovation approach to AI regulation.’

🔹 Key Principles: Safety, transparency, fairness, accountability, and contestability. The MHRA aims to position the UK as a global leader in science and technology by 2030.

🔹 Strategic Focus:

- Regulation: Ensuring AI in medical contexts complies with UK regulations.

- Efficiency: Using AI to speed up regulatory processes and access to medical products.

- Safety: Evidence-based oversight of AI to protect public and patient safety.

🔹 Framework Highlights:

- Pre-market Assessment: Rigorous evaluation of AI medical devices.

- Clinical Evidence: Proof of effectiveness and safety in real-world settings.

- Quality Management: Ensuring consistency and reliability of AI algorithms.

- Post-market Surveillance: Ongoing monitoring for safety and performance.

- Transparency and Accountability: Clear decision-making processes and mechanisms for handling errors.

Find all details here -> https://lnkd.in/eKpEEP9x

🚨 Live Webinar: General Product Safety - Get Ready for December 2024 Deadline! Are you dealing with products under the G...
02/07/2024

🚨 Live Webinar: General Product Safety - Get Ready for December 2024 Deadline!

Are you dealing with products under the GPSD or GPSR regulations? Then this webinar is for you!

📅 Date: Thursday, July 18, 2024

🕓 Time: 4:00 PM - 5:00 PM (UTC+02:00) Brussels, Copenhagen, Madrid, Paris

🎙️ Speaker: Katerina Svambergova, Regulatory Expert

Agenda:

🔹 Transition from Directive (GPSD) to Regulation (GPSR): Key requirements to be compliant with GPSR.

🔹 EU Responsible Person vs. European Authorised Representative: Differences and obligations.

🔹 Online Sales: New requirements for distance selling and who needs to comply.

⏳ Join our upcoming webinar to gain a comprehensive understanding of these crucial topics!

🔗 Register now to secure your spot ->https://lnkd.in/eGKhBmKS

🌟 Join Us at Cosmoprof North America! 🌟We are thrilled to announce our participation in Cosmoprof Las Vegas, happening f...
27/06/2024

🌟 Join Us at Cosmoprof North America! 🌟

We are thrilled to announce our participation in Cosmoprof Las Vegas, happening from 23-25 July in Las Vegas, USA!

➡ Why Meet Us?

Whether you're interested in our services, or simply want to explore potential partnerships, our representatives are ready to engage in as many discussions you need and provide insights tailored to your needs.

📅 Event Details:

Date: 23-25 July

Location: Las Vegas, USA

🔗 Schedule a meeting with one of our company representatives today: https://lnkd.in/eaY57FXz

Looking forward to seeing you at Cosmoprof Las Vegas!

🚀 Clinical Investigations of Medical Devices in the EU 🇪🇺To sell in the EU, manufacturers must demonstrate safety and pe...
24/06/2024

🚀 Clinical Investigations of Medical Devices in the EU 🇪🇺

To sell in the EU, manufacturers must demonstrate safety and performance through clinical data representative of the target population.

🔍 Key Points:
🔸Target Population: Data must match EU demographics.
🔸Non-EU Manufacturers: Conduct investigations in the EU even if not CE-marked.

📋 Clinical Investigation Plan (CIP):
🔸Outlines objectives, design, monitoring, and analysis.
🔸Details for competent authorities to assess risks vs. benefits.

📝 Requirements:
🔸Articles 62-80 MDR: Set investigation guidelines.
🔸Legal Rep: Non-EU sponsors need an EU-based representative.

🌐 Obelis Services:
🔸Review and submit documentation
🔸Manage authorizations and modifications
🔸Communicate investigation status and reports

Find the rest of the details in our latest article ->https://lnkd.in/eHf2Yhqw

🚨 Attention! 🚨There are only 6 working days left to complete the facility registration & product listing for your cosmet...
21/06/2024

🚨 Attention! 🚨

There are only 6 working days left to complete the facility registration & product listing for your cosmetic products. ⏳

Contact Obelis today, and we'll gladly support you in both procedures -> https://lnkd.in/epXQNw8Q

Don't let the deadline catch you!

🌍 UK to Accept Medical Devices from EU, US, Australia, and Canada 🌍Starting 2025, the UK will recognize medical devices ...
20/06/2024

🌍 UK to Accept Medical Devices from EU, US, Australia, and Canada 🌍

Starting 2025, the UK will recognize medical devices compliant with EU, US, Australia, and Canada regulations. This aims to boost medical device supply and enhance patient health.

🔍 Key Points:
🔸CE-marked devices recognized until 30 June 2030.
🔸New compliance routes available.
🔸UKCA marking still an option.

🏥 Requirements:
🔸Compliance with original country's laws.
🔸Upcoming UK post-market surveillance (PMS).
🔸English labels.
🔸Unique Device Identifier (UDI).
🔸UK Responsible Person.

🚫 Exclusions:
🔸Custom-made devices.
🔸Certain medical software.
🔸Get ready for these exciting changes to access the UK market!

Get all the details here -> https://lnkd.in/esdDJF_b

🚨 MoCRA Deadline Approaching: Are You Ready for July 1st? Join us for an essential webinar on Thursday, June 27, 2024, f...
19/06/2024

🚨 MoCRA Deadline Approaching: Are You Ready for July 1st?

Join us for an essential webinar on Thursday, June 27, 2024, from 4:00 PM - 5:00 PM to ensure you're fully prepared for the upcoming MoCRA compliance deadline.

Don't miss out on this opportunity to get all the information you need to stay compliant.

🔗 Register now: https://lnkd.in/eHdD6rv9

Stay ahead of the curve and make sure your business is ready for July 1st!

🚀 Selling Legacy Medical Devices in Switzerland After 26 May 2024 🇨🇭Swiss Medtech's new guidance helps manufacturers wit...
13/06/2024

🚀 Selling Legacy Medical Devices in Switzerland After 26 May 2024 🇨🇭

Swiss Medtech's new guidance helps manufacturers with CE-marked devices post-deadline.

🔍 Key Points:

- Market Restrictions: Non-MDR legacy devices can't be placed on the market in Switzerland/EU after 26 May 2024.
- Existing Devices: Can stay on the market if placed by 26 May 2024.

📋 For MDR Transitioned Devices:

- MDR application and compliant QMS by 26 May 2024 required.
- Requirements: Swiss authorized representative and MedDO compliance.
- Deadline: MDR agreement by 26 September 2024.
- Questions on Swiss, EU, or UK markets? Let’s connect!

Have a look into the full article ->https://obelis.ch/sell-legacy-medical-devices-on-the-swiss-market-after-26-may-2024/

🚨 Its TODAY! MoCRA Deadline July 1st: Is Your Cosmetic Brand Ready? 🗓️ Wednesday, June 12, 2024🕔 5:00 PM - 6:00 PM🎤 Spea...
12/06/2024

🚨 Its TODAY!

MoCRA Deadline July 1st: Is Your Cosmetic Brand Ready?

🗓️ Wednesday, June 12, 2024
🕔 5:00 PM - 6:00 PM
🎤 Speaker: Geoff Waby, Board Director - Obelis USA LLC

Agenda:

⏳ Is Your Cosmetic Brand Ready for the next MoCRA Deadline on July 1st?
📢 Remember: FDA begins enforcing facility registration and product listing.

Register today -> https://obelis.webex.com/weblink/register/r9714f7bb213b288ef0bdd9a0b71ccd8c

Is your Cosmetic Brand ready for MoCRA? Join our webinar and learn about the latest MoCRA deadlines!🗓️ Wednesday, June 1...
11/06/2024

Is your Cosmetic Brand ready for MoCRA?

Join our webinar and learn about the latest MoCRA deadlines!

🗓️ Wednesday, June 12, 2024
🕔 5:00 PM - 6:00 PM
🎤 Speaker: Geoff Waby, Board Director - Obelis USA LLC

Agenda:
⏳ Is Your Cosmetic Brand Ready for the next MoCRA Deadline on July 1st?

📢 Remember: FDA begins enforcing facility registration and product listing.

In the world of beauty, staying ahead is key! All brand owners and manufacturing facilities worldwide selling products in the USA market must be compliant by July 1, 2024.

If you're one of these companies, join this webinar to learn what you need to do to meet the FDA MoCRA requirements before the deadline.

🔗 https:https://obelis.webex.com/weblink/register/r9714f7bb213b288ef0bdd9a0b71ccd8c

In May 2024, the UK announced plans to accept medical devices compliant with EU, US, Australia, and Canada regulations s...
10/06/2024

In May 2024, the UK announced plans to accept medical devices compliant with EU, US, Australia, and Canada regulations starting in 2025. This aims to improve patient health and streamline market access.

🔍 Key Points:

- CE-marked devices from the EU recognized until June 30, 2030.
- New recognition for devices from Australia, Canada, the EU, and the US.
- Requirements: local law compliance, UK post-market surveillance, English labels, unique device identifiers (UDI), and a UK Responsible Person.

❗ Exclusions:

- Certain devices like custom-made devices and specific software.

🌐 UK Responsible Person:

- Non-UK manufacturers must appoint a UK Responsible Person for the UK market.

This initiative enhances the availability and quality of medical devices in the UK. Stay tuned for more updates!

have a look at the full article -> https://www.obelis.co.uk/medical-devices-compliant-eu-us-australia-canada/

Adres

Boulevard Brand Whitlock 30
Brussels
1200

Openingstijden

Maandag 09:00 - 18:00
Dinsdag 09:00 - 18:00
Woensdag 09:00 - 18:00
Donderdag 09:00 - 18:00
Vrijdag 09:00 - 18:00

Telefoon

+3227325954

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Obelis GROUP nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact

Stuur een bericht naar Obelis GROUP:

Video's

Delen

Obelis Story

We are Obelis.

Obelis Group is a leading specialist in European regulatory, directive, and compliance strategy. Its comprehensive CE marking, responsible person, authorized representative, and consultancy services have helped countless European and non-European manufacturers alike introduce their products successfully to the EU market in full compliance with all regulatory standards and requirements.

Founded in 1998, the Obelis Group of companies (including Obelis European Authorized Representatives Center and Obelis European Responsible Person Center) operate as one of the largest regulatory and compliance centers in Europe. It is also a veteran member of the EAAR (European Association of Authorized Representatives) and a founding member of the ERPA (European Cosmetics Responsible Person Association).

Its specialization in the last 30 years has been crucial in proliferating safe, harmonized standards and compliance in the European community, shepherding countless quality products onto the EU market in full regulatory compliance.